Literature DB >> 28929622

Endonuclease Regnase-1/Monocyte chemotactic protein-1-induced protein-1 (MCPIP1) in controlling immune responses and beyond.

Osamu Takeuchi1.   

Abstract

The activation of inflammatory cells is controlled at transcriptional and posttranscriptional levels. Posttranscriptional regulation modifies mRNA stability and translation, allowing for elaborate control of proteins required for inflammation, such as proinflammatory cytokines, prostaglandin synthases, cell surface co-stimulatory molecules, and even transcriptional modifiers. Such regulation is important for coordinating the initiation and resolution of inflammation, and is mediated by a set of RNA-binding proteins (RBPs), including Regnase-1, Roquin, Tristetraprolin (TTP), and AU-rich elements/poly(U)-binding/degradation factor 1 (AUF1). Among these, Regnase-1, also known as Zc3h12a and Monocyte chemotactic protein-1-induced protein-1 (MCPIP1), acts as an endoribonuclease responsible for the degradation of mRNAs involved in inflammatory responses. Conversely, the RBPs Roquin and TTP trigger exonucleolytic degradation of mRNAs by recruiting the CCR4-NOT deadenylase complex. Regnase-1 specifically recognizes stem-loop structures present in 3'-untranslated regions of cytokine mRNAs, and directly degrades the mRNAs in a translation- and ATP-dependent RNA helicase upframeshift 1 (UPF1)-dependent manner that is reminiscent of nonsense-mediated decay. Regnase-1 regulates the activation of innate and acquired immune cells, and is critical for maintaining immune homeostasis as well as preventing over-activation of the immune system under inflammatory conditions. Furthermore, recent studies have revealed that Regnase-1 and its family members are involved not only in immunity but also in various biological processes. In this article, I review molecular mechanisms of Regnase-1-mediated mRNA decay and its physiological roles. WIREs RNA 2018, 9:e1449. doi: 10.1002/wrna.1449 This article is categorized under: RNA Interactions with Proteins and Other Molecules > Protein-RNA Interactions: Functional Implications RNA Turnover and Surveillance > Regulation of RNA Stability RNA in Disease and Development > RNA in Disease.
© 2017 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28929622     DOI: 10.1002/wrna.1449

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev RNA        ISSN: 1757-7004            Impact factor:   9.957


  10 in total

Review 1.  Posttranscriptional regulation of T helper cell fate decisions.

Authors:  Kai P Hoefig; Vigo Heissmeyer
Journal:  J Cell Biol       Date:  2018-04-23       Impact factor: 10.539

2.  Long Non-Coding RNAs Play a Role in the Pathogenesis of Psoriatic Arthritis by Regulating MicroRNAs and Genes Involved in Inflammation and Metabolic Syndrome.

Authors:  Marzia Dolcino; Andrea Pelosi; Piera Filomena Fiore; Giuseppe Patuzzo; Elisa Tinazzi; Claudio Lunardi; Antonio Puccetti
Journal:  Front Immunol       Date:  2018-07-16       Impact factor: 7.561

Review 3.  Post-transcriptional regulation of immune responses by RNA binding proteins.

Authors:  Takashi Mino; Osamu Takeuchi
Journal:  Proc Jpn Acad Ser B Phys Biol Sci       Date:  2018       Impact factor: 3.493

Review 4.  UPFront and center in RNA decay: UPF1 in nonsense-mediated mRNA decay and beyond.

Authors:  Yoon Ki Kim; Lynne E Maquat
Journal:  RNA       Date:  2019-01-17       Impact factor: 4.942

5.  KHNYN is essential for the zinc finger antiviral protein (ZAP) to restrict HIV-1 containing clustered CpG dinucleotides.

Authors:  Harry Wilson; Rui Pedro Galão; Mattia Ficarelli; Michela Mazzon; Irati Antzin-Anduetza; Mark Marsh; Stuart Jd Neil; Chad M Swanson
Journal:  Elife       Date:  2019-07-09       Impact factor: 8.140

Review 6.  More Than Just Attractive: How CCL2 Influences Myeloid Cell Behavior Beyond Chemotaxis.

Authors:  Martha Gschwandtner; Rupert Derler; Kim S Midwood
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

7.  Upregulated endonuclease Regnase-1 suppresses osteoarthritis by forming a negative feedback loop of catabolic signaling in chondrocytes.

Authors:  Jeong-In Yang; Jang-Soo Chun
Journal:  Arthritis Res Ther       Date:  2021-04-14       Impact factor: 5.156

8.  Up-regulated MCPIP1 in abdominal aortic aneurysm is associated with vascular smooth muscle cell apoptosis and MMPs production.

Authors:  Ming Xue; Gang Li; Dan Li; Zhu Wang; Lei Mi; Jingjing Da; Xing Jin
Journal:  Biosci Rep       Date:  2019-11-29       Impact factor: 3.840

9.  MCPIP1 reduces HBV-RNA by targeting its epsilon structure.

Authors:  Yingfang Li; Lusheng Que; Kento Fukano; Miki Koura; Kouichi Kitamura; Xin Zheng; Takanobu Kato; Hussein Hassan Aly; Koichi Watashi; Senko Tsukuda; Hideki Aizaki; Noriyuki Watanabe; Yuko Sato; Tadaki Suzuki; Hiroshi I Suzuki; Kazuyoshi Hosomichi; Makoto Kurachi; Kousho Wakae; Masamichi Muramatsu
Journal:  Sci Rep       Date:  2020-11-27       Impact factor: 4.379

Review 10.  How are MCPIP1 and cytokines mutually regulated in cancer-related immunity?

Authors:  Ruyi Xu; Yi Li; Yang Liu; Jianwei Qu; Wen Cao; Enfan Zhang; Jingsong He; Zhen Cai
Journal:  Protein Cell       Date:  2020-06-16       Impact factor: 14.870

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.